The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
May 19th 2024
With agents like semaglutide and tirzepatide becoming household drug names, Peterson discusses the short-term future of incretin drug development.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Depression Following a Coronary Event Increases Risk of Death
September 16th 2009Patients who suffer from depression in the first several weeks after being hospitalized for a coronary event and those patients whose depression does not improve over six months are at an increased risk of death compared to coronary patients who are not depressed.
Cardiac Biomarker May Provide New Tool for Diagnosing Post-Surgical MI
September 10th 2009Researchers from the Heart Center at Massachusetts General Hospital have discovered that, in patients who are recovering from coronary-artery bypass grafting, high levels of a particular biomarker may be a new prognostic tool for diagnosing heart attacks.
Seas of Change for Inpatient Glucose Management
September 4th 2009Making the transition from outpatient to inpatient has been thankfully only a slightly “bumpy” road, but it is amazing looking back on how our approach to inpatient diabetes care and hyperglycemia on the whole has changed over the past 10 years.
New Gene Expression Test will make Diagnosing Coronary Artery Disease Simpler
September 1st 2009CardioDX has completed a multi-center study validating the effectiveness of Corus CAD, the self-billed “first and only gene expression test to quantify the likelihood of obstructive coronary artery disease (CAD) in patients with stable chest pain.”
Antihypertensive Combination Drugs: Effectiveness, Adherence, and Pleiotropic Effects
The decreasing age of onset of hypertension in the general population paired with increasing life expectancy has resulted in an increased incidence of this disorder, which will likely culminate in higher rates of morbidity and mortality in the future.
Activation of HIF Protein may Become New Treatment for Ischemic Pathologies
August 20th 2009A team of researchers from the Cardiovascular Research Center in Paria and CIC bioGUNE, an international center for biomedical research discovered that the activation of a cellular protein may be the key to a new treatment for ischemic pathologies.
Cognitive Problems in Heart Disease Patients Not Due to Heart-Lung Machines
August 4th 2009Long-term memory loss and cognitive problems that heart bypass patients suffer after surgery are due to the underlying coronary artery disease and not the use of a heart-lung machine during surgery, new research shows.
Internet-based Interventions Help Reduce Coronary Heart Disease Risk
June 30th 2009According to a recent study, the communication via phone and Internet between patients and healthcare providers is “an effective way to reduce risk factors for coronary heart disease and the risk of further events after a heart attack.”